Research Articles | Page 3 | Aplastic Anemia & MDS International Foundation Return to top.
  1. Articles
  2. Research Articles

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
A Meta-Analysis of the Relationship between Cigarette Smoking and Incidence of Myelodysplastic Syndromes. Jun 2013 PLoS One myelodysplastic syndromes (MDS)
A Meta-Analysis of the Relationship between Cigarette Smoking and Incidence of Myelodysplastic Syndromes. Jun 2013 PLoS One myelodysplastic syndromes (MDS)
A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial. Apr 2013 Haematologica myelodysplastic syndromes (MDS)
A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes. Jun 2013 Bone Marrow Transplant myelodysplastic syndromes (MDS)
A novel histone deacetylase inhibitor Chidamide induces G0/G1 arrest and apoptosis in myelodysplastic syndromes Oct 2016 Biomed Pharmacother myelodysplastic syndromes (MDS)
A novel marker for screening paroxysmal nocturnal hemoglobinuria using routine complete blood count and cell population data Jan 2015 Ann Lab Med paroxysmal nocturnal hemoglobinuria (PNH)
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes Aug 2020 Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation myelodysplastic syndromes (MDS)
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes Nov 2020 Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation myelodysplastic syndromes (MDS)
A Phase 1 Study of Oral ARRY-614, a p38 MAPK/Tie2 Dual Inhibitor, in Patients with Low or Intermediate 1 Risk Myelodysplastic Syndromes Dec 2014 Clin Cancer Res myelodysplastic syndromes (MDS)
A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasia Oct 2016 Br J Haematol myelodysplastic syndromes (MDS)
Share with addtoany.com.